ERIC WEINSTOCK: Open Payments
NPI 1679554687 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,086 in 209 payments from 22 companies in 2025. Trend: 2023 $6,311 · 2024 $3,503 · 2025 $5,086
Food & beverage: $5,086
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $961 |
| Axsome Therapeutics, Inc. | 15 | $574 |
| Alkermes, Inc. | 16 | $382 |
| Otsuka America Pharmaceutical, Inc. | 21 | $350 |
| Vanda Pharmaceuticals Inc. | 10 | $348 |
| Neurocrine BioSciences, Inc. | 16 | $299 |
| Noven Therapeutics, LLC | 15 | $287 |
| ABBVIE INC. | 15 | $254 |
| Corium, LLC | 12 | $237 |
| Teva Pharmaceuticals USA, Inc. | 9 | $212 |
Products named: CAPLYTA, REXULTI, Auvelity, INGREZZA, Xelstrym, FANAPT, VRAYLAR, Sunosi.
Industry payments across FL — which companies pay providers there.
